Is a complete CSE/XCX research report available?

Question

Accepted Answer

No complete published report is available for cse/XCX (CSE/XCX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	258.3K
Net income (ttm)	-1.3M
EPS (ttm)	-CA$0.03
Shares out	51.7M
Volume	20,000
Beta	0.62

Metric	Value
Country	Canada
Country code	CA
Employees	250
Enterprise value	CAD 4.7M
Exchange	Canadian Securities Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	22.31
Isin	CA39540L1085
Last refreshed	2026-09-07
Market cap	CAD 258,277
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	6799
Symbol	cse/XCX
Website	https://greenriseglobal.com

Metric	Value
Earnings Yield	-497.84%
FCF yield	-55.24%
P/B ratio	-0.05x

Metric	Value
Net Income	CAD -1.3M
Net Income Growth Years	0%
Profit Per Employee	CAD -5,143
ROA	-29.42
Roa5y	-122.8
ROCE	3.63
ROIC	-87.38

Metric	Value
Cagr10y	-20.57%
Cagr15y	-22.85%
Cagr20y	-19.79%
Cagr3y	-41.51%
Cagr5y	-57%
EPS Growth Years	0
Revenue Growth Years	0x

CSE/XCX (CSE/XCX)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/XCX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/XCX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/XCX

Frequently asked questions

Metric	Value
Assets	CAD 2,134
Cash	CAD 2,134
Current Assets	CAD 2,099
Current Liabilities	CAD 4.6M
Debt	CAD 4.5M
Debt FCF	CAD -31.33
Equity	CAD -4.7M
Interest Coverage	-0.42
Liabilities	CAD 4.7M
Long Term Assets	CAD 34.66
Long Term Liabilities	CAD 77,353
Net Cash	CAD -4.5M
Net Cash By Market Cap	CAD -1,730
Tangible Book Value	CAD -4.7M
Tangible Book Value Per Share	CAD -0.09
WACC	7.16

Metric	Value
Current ratio	0
Net Working Capital	CAD -244,459
Quick ratio	0
Working Capital	CAD -4.7M

Metric	Value
Buyback Yield	-4.33%
Dividend per share	CAD 0
Last Dividend	CAD 0.53

Metric	Value
10Y total return	-90%
200-day SMA	0.03
3Y total return	-80%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.53%
All Time High	8
All Time High Change	-99.94%
All Time High Date	2004-10-05
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2024-02-07
ATR	0
Beta	0.62
Beta1y	3.09
Beta2y	-0.63
High	0.01
High52	0.02
High52 Date	2026-01-23
High52ch	-66.67%
Low	0.01
Low52	0.01
Low52 Date	2026-05-12
Low52ch	0%
Ma50ch	-24.24%
Price vs 200-day SMA	-84.42%
RSI	45.54
RSI Monthly	40.36
RSI Weekly	36.77
Sharpe ratio	2.27x
Sharpe Ratio3y	1.45x
Sharpe Ratio5y	1.23x
Sortino ratio	6.66
Sortino Ratio3y	4.06
Sortino Ratio5y	3.23
Total Return	-4.33%
Tr15y	-97.96%
Tr3m	-50%

Metric	Value
Float	41,661,301%
Net Borrowing	-27,524.5
Shares Insiders	14.12%
Shares Institutions	3.28%
Shares Out	51,655,369
Shares Qo Q	0.68%
Shares Yo Y	4.33%

Metric	Value
Average Volume	104,472.95x
Bv Per Share	-0.09
Ch10y	-90
Ch15y	-99.76
Ch20y	-99.86
Ch3m	-50
Ch3y	-80
Ch5y	-98.53
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Dollar Volume	100
Earnings Date	2026-11-27
EBIT	CAD -171,022
EPS	CAD -0.03
F Score	1
FCF	CAD -142,676
FCF EV Yield	-3.02x
FCF Per Share	CAD -0
Financing CF	-27,984
Fiscal Year End	December
Investing CF	147,084
Is Primary Listing	1
Last Earnings Date	2025-11-20
Last Report Date	2025-09-30
Last Split Date	2018-12-13
Last Split Type	Forward
Ma150	0.01
Ma150ch	-57.98%
Ma20	0.01
Ma20ch	-35.9%
Net CF	-25,956
Next Earnings Date	2026-11-27
Open	0.01
Price Date	2026-03-25
Relative Volume	0.19x
Tr20y	-98.78%
Volume	20,000